Predictive Factors for Primary and Secondary Nonresponders to Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis: A Real-World Study DOI
Teppei Hagino, Hidehisa Saeki,

Eita Fujimoto

et al.

Dermatitis, Journal Year: 2024, Volume and Issue: unknown

Published: Dec. 5, 2024

Some patients with atopic dermatitis (AD) do not sufficiently respond to upadacitinib, a Janus kinase 1 inhibitor. However, predictive factors for nonresponders remain unclear in real-world practice.

Language: Английский

Predictive Factors for Primary and Secondary Nonresponders to Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis: A Real-World Study DOI
Teppei Hagino, Hidehisa Saeki,

Eita Fujimoto

et al.

Dermatitis, Journal Year: 2024, Volume and Issue: unknown

Published: Dec. 5, 2024

Some patients with atopic dermatitis (AD) do not sufficiently respond to upadacitinib, a Janus kinase 1 inhibitor. However, predictive factors for nonresponders remain unclear in real-world practice.

Language: Английский

Citations

1